Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases. Maystrenko, D. Nanobiotechnology Reports, 18(4):650–657, 2023. Query date: 2024-02-01 14:42:56doi bibtex @Article{pop00006,
author = {D.N. Maystrenko},
title = {Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases},
doi = {10.1134/S2635167623600165},
issn = {2635-1676},
note = {Query date: 2024-02-01 14:42:56},
number = {4},
pages = {650--657},
volume = {18},
citation = {https://api.elsevier.com/content/abstract/scopus_id/85180548770},
journal = {Nanobiotechnology Reports},
type = {Article},
year = {2023},
}
Downloads: 0
{"_id":"riP9rKrosLmHcQveC","bibbaseid":"maystrenko-pharmaceuticaldevelopmentofinnovativerussianradiopharmaceuticalsbasedonbispecificnanoantibodiestogitrandctla4forthetheranosticsofoncologicaldiseases-2023","author_short":["Maystrenko, D."],"bibdata":{"bibtype":"article","type":"Article","author":[{"firstnames":["D.N."],"propositions":[],"lastnames":["Maystrenko"],"suffixes":[]}],"title":"Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases","doi":"10.1134/S2635167623600165","issn":"2635-1676","note":"Query date: 2024-02-01 14:42:56","number":"4","pages":"650–657","volume":"18","citation":"https://api.elsevier.com/content/abstract/scopus_id/85180548770","journal":"Nanobiotechnology Reports","year":"2023","bibtex":"@Article{pop00006,\n author = {D.N. Maystrenko},\n title = {Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases},\n doi = {10.1134/S2635167623600165},\n issn = {2635-1676},\n note = {Query date: 2024-02-01 14:42:56},\n number = {4},\n pages = {650--657},\n volume = {18},\n citation = {https://api.elsevier.com/content/abstract/scopus_id/85180548770},\n journal = {Nanobiotechnology Reports},\n type = {Article},\n year = {2023},\n}\n\n","author_short":["Maystrenko, D."],"key":"pop00006","id":"pop00006","bibbaseid":"maystrenko-pharmaceuticaldevelopmentofinnovativerussianradiopharmaceuticalsbasedonbispecificnanoantibodiestogitrandctla4forthetheranosticsofoncologicaldiseases-2023","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bio.pnpi.nrcki.ru/wp-content/uploads/2024/02/czdki.txt","dataSources":["s4KAFFPQzxe3CETeY"],"keywords":[],"search_terms":["pharmaceutical","development","innovative","russian","radiopharmaceuticals","based","bispecific","nanoantibodies","gitr","ctla","theranostics","oncological","diseases","maystrenko"],"title":"Pharmaceutical Development of Innovative Russian Radiopharmaceuticals Based on Bispecific Nanoantibodies to Gitr and Ctla-4 for the Theranostics of Oncological Diseases","year":2023}